Health News

Latest articles in Health

US measles cases pass 5,000 as the death toll reaches double digits

The United States has recorded 5,412 confirmed measles cases in 2026, the first time above 5,000 since 1991, and state health departments count 10 measles-related deaths. The CDC lists six, double the 2025 figure, after switching from state tallies to national mortality data. Pennsylvania has confirmed six deaths, Wisconsin reported an infant's death and New York recorded its first in more than 30 years. Of this year's patients, 20 percent are children five and under and 93 percent were unvaccinated or of unknown status. The Pan American Health Organization was expected to decide whether the country keeps its measles-free certification.

Shingles shot tied to less heart disease in a seven-year comparison

Adults who received the recombinant shingles vaccine Shingrix had a 9% lower burden of cardiovascular disease over seven years than those who got the older live vaccine, according to a study in Nature Medicine. Heart failure and ischaemic heart disease drove the difference, and the authors say the finding is a signal that needs testing in a randomised trial.

FDA clears asundexian to cut repeat stroke risk

The FDA approved asundexian, sold as Sunharbo, on November 9 to reduce the risk of stroke in adults who have had a recent mild-to-moderate non-cardioembolic ischemic stroke or a high-risk transient ischemic attack. The drug targets factor XIa, a clotting protein, and is part of a class built to prevent clots with less bleeding than older blood thinners. The approval is one of 48 new drugs cleared by the agency in 2026, a list that also includes bepirovirsen for chronic hepatitis B, approved in October.

US nears loss of measles elimination status as 2026 cases pass 5,100

The United States is close to losing the measles elimination status it has held since 2000, with 5,182 confirmed cases reported as of November 5 and six deaths this year. The CDC has logged 38 outbreaks, and nearly all cases were acquired inside the country rather than imported. About 20 percent of patients are children aged five and under, and 93 percent are unvaccinated or have unknown vaccine status. The Pan American Health Organization is reviewing whether a year of continuous transmission has ended elimination. This is the worst US measles year since 1991, and coverage with two doses has slipped below 90 percent in several states, well under the roughly 95 percent needed to stop transmission.

Cancer society now recommends routine PSA screening for most men

The American Cancer Society issued a new prostate cancer screening guideline on Thursday that, for the first time, directly recommends routine PSA blood testing rather than leaving it to a discussion between doctor and patient. Average-risk men aged 50 to 69 should be tested every two years. Black men and men with a strong family history should start at 45 and test every year. The change rests on a systematic evidence review that found screening lowers deaths and advanced-stage diagnoses. The society estimates 333,830 new prostate cancer cases and 36,320 deaths in the United States this year.

Global study backs waist-based obesity diagnosis over BMI alone

A study published in Nature on 11 November tested the Lancet Commission's obesity framework against the standard BMI cut-offs in cohorts from several countries with long-term follow-up. The framework counts people as obese if BMI is 40 or higher, or if BMI is 30 or higher plus a raised waist circumference or waist-to-height ratio, or if BMI is 25 to 29.9 plus both measures, with lower thresholds for Chinese populations. Researchers report that people in the overweight BMI range who met the added criteria had death rates close to those of people with BMI in the obese range, supporting the wider definition. A separate US analysis found a simpler rule performed better against body scans.

FDA approves XFG-targeted COVID vaccines for 2026-27 season

The US Food and Drug Administration approved updated COVID-19 vaccines for the 2026-27 season, with four products cleared: Pfizer-BioNTech's Comirnaty, Moderna's Spikevax and mNEXSPIKE, and Novavax's Nuvaxovid. The new formulas target XFG, a variant in the JN.1 lineage that advisers recommended in May. The vaccines are approved for adults 65 and older and for younger people with conditions that raise the risk of severe illness. Pfizer said shipping would begin immediately. The CDC said its existing recommendations for the 2026-27 respiratory season remain in effect while legal questions about federal guidance are unresolved. Pfizer said it would begin shipping doses immediately, with other makers following in the coming weeks.

Bone drugs linked to lower dementia risk in 120,000-person study

A study of more than 120,000 older adults in Hong Kong found that people taking nitrogen-containing bisphosphonates for osteoporosis were 16 percent less likely to develop Alzheimer's disease or other dementias than untreated patients, and 24 percent less likely than those on other bone medicines. Over five years the absolute risk fell about 2.1 percentage points, and 48 patients would need treatment to prevent one case. The link was strongest in women and hip fracture patients. The work is observational, so it points to a trial rather than a prescription. The authors controlled for age, sex and other prescriptions, but say a randomised trial is needed.

Blood protein prestin may give tinnitus its first objective test

Researchers at the University of Connecticut found that people with tinnitus had about 50 percent more of the ear protein prestin in their blood than people without it. The study, published in Otolaryngology - Head and Neck Surgery, covered 82 adults. If the finding holds in larger trials, it could give doctors the first objective test for a condition that affects roughly 15 percent of the world's population.

Weight-loss surgery tied to about 20% lower risk of obesity-related cancer

People with obesity who had bariatric surgery were about 20% less likely to develop cancers linked to excess weight, according to a registry study of more than 780,000 people in Sweden, Denmark and Finland, of whom nearly 100,000 had the operation. The work, led from the Karolinska Institute and published in JAMA Surgery, covered ten obesity-related cancers and found similar reductions for men and women and across age groups. The authors stress that weight loss remains the reason to operate, not cancer prevention, but argue the findings support equal access to surgery when it is clinically indicated. Registry data cannot prove cause and effect.